Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Nov;2(6):740–746. doi: 10.1128/cdli.2.6.740-746.1995

Expression of recombinant feline tumor necrosis factor is toxic to Escherichia coli.

C M Otto 1, F Niagro 1, X Su 1, C A Rawlings 1
PMCID: PMC170231  PMID: 8574840

Abstract

The tumor necrosis factor (TNF) genes from cats, horses, and pigs have all been cloned into the pFLAG-1 fusion protein expression vector (International Biotechnologies, Inc., Kodak, New Haven, Conn.). Growth curves for Escherichia coli containing the pFLAG-1 vector alone and the pFLAG-1 vector containing the TNF gene from each species were determined by visible light spectrophotometry (at 600 nm). Porcine TNF, equine TNF, and feline TNF cultures had slower doubling rates than cultures containing the pFLAG-1 vector alone. Cultures of cells transformed with feline TNF reached peak densities at 3 to 4 h and then decreased to near initial densities prior to the recovery of growth. The induction of expression with isopropyl-beta-D-thiogalactopyranoside (IPTG) arrested the growth of fresh feline TNF cultures for 6 h, which was followed by complete recovery. This inhibition occurred in two strains of E. coli (LL308 and JM101). Induced feline TNF cultures expressed the TNF-FLAG fusion protein for the first 6.5 h. Uninduced cultures expressed low levels of fusion protein. The feline TNF-pFLAG-1 vector was purified from cells expressing fusion protein and from cells with recovered growth curves. Sequencing the vector demonstrated the complete feline TNF gene and tac promoter in cells expressing the fusion protein and a deletional mutation of the tac promoter site in recovered cells. In contrast to equine and porcine TNF, the expression of recombinant feline TNF is toxic to E. coli. Alterations in protein folding and the prevention of secretion of the feline protein may explain the toxic effect.

Full Text

The Full Text of this article is available as a PDF (693.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beutler B., Krochin N., Milsark I. W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 1986 May 23;232(4753):977–980. doi: 10.1126/science.3754653. [DOI] [PubMed] [Google Scholar]
  2. Bromberg J. S., Chavin K. D., Kunkel S. L. Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo. J Immunol. 1992 Jun 1;148(11):3412–3417. [PubMed] [Google Scholar]
  3. Chen W., Havell E. A., Harmsen A. G. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect Immun. 1992 Apr;60(4):1279–1284. doi: 10.1128/iai.60.4.1279-1284.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Espevik T., Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986 Dec 4;95(1):99–105. doi: 10.1016/0022-1759(86)90322-4. [DOI] [PubMed] [Google Scholar]
  5. Gehr G., Gentz R., Brockhaus M., Loetscher H., Lesslauer W. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J Immunol. 1992 Aug 1;149(3):911–917. [PubMed] [Google Scholar]
  6. Haynes D. R., Whitehouse M. W., Vernon-Roberts B. The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology. 1992 Jun;76(2):251–257. [PMC free article] [PubMed] [Google Scholar]
  7. Ito H., Shirai T., Yamamoto S., Akira M., Kawahara S., Todd C. W., Wallace R. B. Molecular cloning of the gene encoding rabbit tumor necrosis factor. DNA. 1986 Apr;5(2):157–165. doi: 10.1089/dna.1986.5.157. [DOI] [PubMed] [Google Scholar]
  8. Ito H., Yamamoto S., Kuroda S., Sakamoto H., Kajihara J., Kiyota T., Hayashi H., Kato M., Seko M. Molecular cloning and expression in Escherichia coli of the cDNA coding for rabbit tumor necrosis factor. DNA. 1986 Apr;5(2):149–156. doi: 10.1089/dna.1986.5.149. [DOI] [PubMed] [Google Scholar]
  9. Jones E. Y., Stuart D. I., Walker N. P. Crystal structure of TNF. Immunol Ser. 1992;56:93–127. [PubMed] [Google Scholar]
  10. Jättelä M. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab Invest. 1991 Jun;64(6):724–742. [PubMed] [Google Scholar]
  11. Knapp M. L., al-Sheibani S., Riches P. G., Hanham I. W., Phillips R. H. Hormonal factors associated with weight loss in patients with advanced breast cancer. Ann Clin Biochem. 1991 Sep;28(Pt 5):480–486. doi: 10.1177/000456329102800510. [DOI] [PubMed] [Google Scholar]
  12. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. Lin K. H., Cheng S. Y. An efficient method to purify active eukaryotic proteins from the inclusion bodies in Escherichia coli. Biotechniques. 1991 Dec;11(6):748, 750, 752-3. [PubMed] [Google Scholar]
  14. Lähdevirta J., Maury C. P., Teppo A. M., Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med. 1988 Sep;85(3):289–291. doi: 10.1016/0002-9343(88)90576-1. [DOI] [PubMed] [Google Scholar]
  15. McGraw R. A., Coffee B. W., Otto C. M., Drews R. T., Rawlings C. A. Gene sequence of feline tumor necrosis factor alpha. Nucleic Acids Res. 1990 Sep 25;18(18):5563–5563. doi: 10.1093/nar/18.18.5563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Otto C. M., Rawlings C. A. Tumor necrosis factor production in cats in response to lipopolysaccharide: an in vivo and in vitro study. Vet Immunol Immunopathol. 1995 Nov;49(1-2):183–188. doi: 10.1016/0165-2427(95)05456-g. [DOI] [PubMed] [Google Scholar]
  17. Pesanti E. L. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro. J Infect Dis. 1991 Mar;163(3):611–616. doi: 10.1093/infdis/163.3.611. [DOI] [PubMed] [Google Scholar]
  18. Rimstad E., Reubel G. H., Dean G. A., Higgins J., Pedersen N. C. Cloning, expression and characterization of biologically active feline tumour necrosis factor-alpha. Vet Immunol Immunopathol. 1995 Apr;45(3-4):297–310. doi: 10.1016/0165-2427(94)05345-S. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Scuderi P., Sterling K. E., Lam K. S., Finley P. R., Ryan K. J., Ray C. G., Petersen E., Slymen D. J., Salmon S. E. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet. 1986 Dec 13;2(8520):1364–1365. doi: 10.1016/s0140-6736(86)92007-6. [DOI] [PubMed] [Google Scholar]
  20. Seckler R., Jaenicke R. Protein folding and protein refolding. FASEB J. 1992 May;6(8):2545–2552. doi: 10.1096/fasebj.6.8.1592207. [DOI] [PubMed] [Google Scholar]
  21. Squadrito F., Ioculano M., Altavilla D., Zingarelli B., Canale P., Campo G. M., Saitta A., Calapai G., Bussolino F., Caputi A. P. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury. J Lipid Mediat. 1993 Aug;8(1):53–65. [PubMed] [Google Scholar]
  22. Su X., Morris D. D., Crowe N. A., Moore J. N., Fischer K. J., McGraw R. A. Equine tumor necrosis factor alpha: cloning and expression in Escherichia coli, generation of monoclonal antibodies, and development of a sensitive enzyme-linked immunosorbent assay. Hybridoma. 1992 Dec;11(6):715–727. doi: 10.1089/hyb.1992.11.715. [DOI] [PubMed] [Google Scholar]
  23. Su X., Prestwood A. K., McGraw R. A. Production of recombinant porcine tumor necrosis factor alpha in a novel E. coli expression system. Biotechniques. 1992 Nov;13(5):756–762. [PubMed] [Google Scholar]
  24. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tracey K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R. J., Fahey T. J., 3rd, Zentella A., Albert J. D. Shock and tissue injury induced by recombinant human cachectin. Science. 1986 Oct 24;234(4775):470–474. doi: 10.1126/science.3764421. [DOI] [PubMed] [Google Scholar]
  26. Zhou C., Yang Y., Jong A. Y. Mini-prep in ten minutes. Biotechniques. 1990 Feb;8(2):172–173. [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES